| Health / Medical Topics |
Antibody-Drug Conjugate DFRF4539A
An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against a specific myeloma antigen and conjugated to monomethyl auristatin E (MMAE), an auristatin derivative and a potent microtubule inhibitor, with potential antineoplastic activity. Upon administration, the monoclonal antibody moiety of DFRF4539A selectively binds to a specific protein expressed on the surface of myeloma cells. Upon internalization and proteolytic cleavage, MMAE binds to tubulin and inhibits its polymerization, which results in G2/M phase arrest and tumor cell apoptosis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance made up of a monoclonal antibody chemically linked to a drug. The monoclonal antibody binds to specific proteins or receptors…
A systemic therapy which ensures that a specific prodrug is not converted into the active moiety anywhere but at the sites where…
A type of immune reaction in which a target cell or microbe is coated with antibodies and killed by certain types of…
A type of immune reaction in which a target cell or microbe is coated with antibodies and killed by certain types of…
A unit of antibody concentration measured by comparison against a known concentration of antibodies in a standard reference specimen.
Concentration in serum of the antibody that recognizes a particular epitope expressed as the reciprocal of the highest serum dilution that produces…
